[Federal Register Volume 67, Number 44 (Wednesday, March 6, 2002)]
[Notices]
[Pages 10223-10224]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-5309]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Request for Comments Regarding the Prevention, Identification, 
and Treatment of Co-occurring Disorders

    In compliance with section 503A of the Public Health Service Act 
(42 U.S.C. 290aa-2a), the Substance Abuse and Mental Health Services 
Administration (SAMHSA) is required to provide to the United States 
Congress a report on the prevention, identification, and treatment of 
co-occurring disorders. Public comment is solicited in order to aid in 
the development of this report.

SUMMARY: The report, due by October 17, 2002, is mandated to include 
the following:
     A summary of the manner in which individuals with co-
occurring disorders are receiving treatment.
     A summary of improvements necessary to ensure that 
individuals with co-occurring mental illnesses and substance abuse 
disorders receive the services they need.
     A summary of practices for preventing substance abuse 
among individuals who have a mental illness and are at risk of having 
or acquiring a substance abuse disorder.
     A summary of evidence-based practices for treating 
individuals with co-occurring disorders and recommendations for 
implementing such practices.
    We understand that your time is limited and you probably will not 
be able to respond to every issue. Where possible, however, it would be 
most helpful in responding to the key issues outlined below if you 
could identify those issues that you consider to be either a major 
problem or a minor problem. Further, for those issues that you consider 
to be a major problem, it would be helpful if you could explain the 
source of your concern and your recommendations for responding to the 
issue. Finally, you are in no way limited to the list below. If there 
are additional major problems related to the prevention, identification 
and treatment of co-occurring disorders that should come to the 
attention of SAMHSA, please describe and comment on those as well.
    The issues are organized by topic area in an outline form. For 
example, issue A.1., ``Commitment demonstrated by key decision-makers 
to address co-occurring disorders,'' is under the System-Level topic 
area. It would be appreciated if you would provide your responses using 
the alphanumeric designations in this outline (e.g., A.1., B.1., etc.). 
This will allow us to process your indications of major and minor 
problem areas and your concerns and recommendations most efficiently.

A. System-Level Issues

    1. Commitment demonstrated by key decision-makers to address co-
occurring disorders.
    2. Presence of an interagency coordinating body.
    3. Presence of a strategic plan guiding community/interagency 
activities.
    4. Opportunities for cross-training of staff.
    5. Presence of interagency agreements.
    6. Uniform application and eligibility criteria.
    7. Pooled or joint funding.
    8. Co-occurring disorders regarded as a likely presentation, not an 
exception.
    9. Community efforts to reduce stigma of both disorders and 
encourage treatment.

[[Page 10224]]

B. Program-Level Issues

Access

    1. Admission criteria that recognize the multifaceted needs of 
clients with co-occurring disorders.
    2. Availability of professional staff trained in the area of co-
occurring disorders.
    3. Availability of staff whose culture(s) and language(s) match 
those of clients.
    4. Services available at nontraditional hours (e.g. evenings and 
weekends).
    5. Outreach to individuals not connected to the system.

Screening

    6. Screening for both disorders.
    7. Standardized instruments normed for gender and culture, and 
policies, and procedures that reflect gender and culture.
    8. Level of accuracy in detecting the presence and severity of both 
disorders.

Assessment

    9. Methods that allow for accurate recognition of the interaction 
between serious mental illnesses and substance abuse disorders.
    10. Methods that are sufficiently comprehensive to allow for the 
entire range of client need.
    11. Methods that are gender and culturally relevant.

Treatment

    12. Process for flexible and individualized plans.
    13. Use of clinical treatment guidelines for co-occurring 
disorders.
    14. Use of staged interventions (e.g., engagement, persuasion, 
active treatment, relapse).
    15. Longitudinal perspective.
    16. Recognition of non-linear recovery process for both disorders.
    17. Provisions for relapse.
    18. Services for both disorders available concurrently, with the 
same agency.
    19. Clients participate in developing treatment plans.
    20. Availability of social support networks.
    21. Assistance in securing needed wraparound services (housing, 
employment, childcare, etc.)

Follow-Up

    22. Discharge planning policies and procedures that account for the 
full range of community supports that are required.
    23. Long-term follow-up as standard practice.
    24. Policies and procedures to address relapse to substance use 
and/or reoccurrence of psychiatric symptoms.

C. Prevention Issues

    1. Interventions directed at risk and protective factors, rather 
than specific problem behaviors.
    2. Longitudinal interventions (e.g., from kindergarten to high 
school).
    3. Interventions designed for appropriate developmental stages.
    4. Interventions that focus on the child at home and in school.
    5. School-based programs that use a well-tested, standardized 
intervention with detailed lesson plans and student materials.
    6.Family-based interventions that include skills training for 
parents.
    7. Interventions that use media and community education strategies 
to increase public awareness and support.
    8. Links between prevention programs and treatment systems.
    9. Interventions that are universal (for all), selective (for those 
at risk), and indicated (for those at highest risk).

D. Research and Evaluation Issues

    1. Availability of prevalence data for planning.
    2. Availability of measures of access and cost.
    3. Availability of measures of quality of care, including 
monitoring and quality assurance for the treatment of both disorders.
    4. Availability of outcome measures, including quality of life, 
clinical and functional improvement, and maintenance and relapse 
prevention.
    5. Data linked across programs and systems.
    6. Management information systems designed to gather and analyze 
data on both disorders.
    7. Adequate resources for data collection and evaluation.

DATES: In order for comments to be considered in the development of 
this policy report on co-occurring disorders, they must be received no 
later than March 27, 2002.

ADDRESSES: All comments should be sent to James Winarski; Advocates for 
Human Potential; 323 Boston Post Road; Sudbury, MA 01776.

FOR FURTHER INFORMATION CONTACT: Eileen Elias, M.Ed., Special Expert, 
SAMHSA, 301-443-8742

    Dated: February 28, 2002.
Richard Kopanda,
Executive Officer, SAMHSA.
[FR Doc. 02-5309 Filed 3-5-02; 8:45 am]
BILLING CODE 4162-20-P